131 related articles for article (PubMed ID: 37740534)
21. Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.
Dahlstrom KR; Garden AS; William WN; Lim MY; Sturgis EM
J Clin Oncol; 2016 Jun; 34(16):1848-54. PubMed ID: 26884553
[TBL] [Abstract][Full Text] [Related]
22. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
[TBL] [Abstract][Full Text] [Related]
23. Potential therapeutic implications of the new tumor, node, metastasis staging system for human papillomavirus-mediated oropharyngeal cancer.
Huang SH; Li J; Xu Z; O'Sullivan B
Curr Opin Otolaryngol Head Neck Surg; 2020 Apr; 28(2):100-106. PubMed ID: 32022732
[TBL] [Abstract][Full Text] [Related]
24. Additional parameters to improve the prognostic value of the 8th edition of the UICC classification for human papillomavirus-related oropharyngeal tumors.
Straetmans JMJAA; Stuut M; Lacko M; Hoebers F; Speel EM; Kremer B
Head Neck; 2022 Aug; 44(8):1799-1815. PubMed ID: 35579041
[TBL] [Abstract][Full Text] [Related]
25. Machine Learning Prediction of Extracapsular Extension in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Hatten KM; Amin J; Isaiah A
Otolaryngol Head Neck Surg; 2020 Nov; 163(5):992-999. PubMed ID: 32600154
[TBL] [Abstract][Full Text] [Related]
26. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
[TBL] [Abstract][Full Text] [Related]
27. Societal cost of oropharyngeal cancer by human papillomavirus status, cancer stage, and subsite.
Silfverschiöld M; Sjövall J; Wennerberg J; Östensson E; Greiff L
PLoS One; 2019; 14(7):e0220534. PubMed ID: 31356646
[TBL] [Abstract][Full Text] [Related]
28. Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trial.
Kann BH; Likitlersuang J; Bontempi D; Ye Z; Aneja S; Bakst R; Kelly HR; Juliano AF; Payabvash S; Guenette JP; Uppaluri R; Margalit DN; Schoenfeld JD; Tishler RB; Haddad R; Aerts HJWL; Garcia JJ; Flamand Y; Subramaniam RM; Burtness BA; Ferris RL
Lancet Digit Health; 2023 Jun; 5(6):e360-e369. PubMed ID: 37087370
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
30. Clinical variables and magnetic resonance imaging-based radiomics predict human papillomavirus status of oropharyngeal cancer.
Bos P; van den Brekel MWM; Gouw ZAR; Al-Mamgani A; Waktola S; Aerts HJWL; Beets-Tan RGH; Castelijns JA; Jasperse B
Head Neck; 2021 Feb; 43(2):485-495. PubMed ID: 33029923
[TBL] [Abstract][Full Text] [Related]
31. An interpretable machine learning prognostic system for risk stratification in oropharyngeal cancer.
Alabi RO; Almangush A; Elmusrati M; Leivo I; Mäkitie AA
Int J Med Inform; 2022 Dec; 168():104896. PubMed ID: 36279655
[TBL] [Abstract][Full Text] [Related]
32. Validation of the 8
van Gysen K; Stevens M; Guo L; Jayamanne D; Veivers D; Wignall A; Pang L; Guminski A; Lee A; Hruby G; Macleod P; Taylor A; Eade T
BMC Cancer; 2019 Jul; 19(1):674. PubMed ID: 31288767
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
[TBL] [Abstract][Full Text] [Related]
34. Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
Ho AS; Luu M; Kim S; Tighiouart M; Mita AC; Scher KS; Mallen-St Clair J; Walgama ES; Lin DC; Nguyen AT; Zumsteg ZS
Cancer; 2021 May; 127(10):1590-1597. PubMed ID: 33595897
[TBL] [Abstract][Full Text] [Related]
35. Surrogate for oropharyngeal cancer HPV status in cancer database studies.
Megwalu UC; Chen MM; Ma Y; Divi V
Head Neck; 2017 Dec; 39(12):2494-2500. PubMed ID: 28963794
[TBL] [Abstract][Full Text] [Related]
36. Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Mizumachi T; Kano S; Sakashita T; Hatakeyama H; Suzuki S; Homma A; Oridate N; Fukuda S
Int J Clin Oncol; 2013 Oct; 18(5):824-8. PubMed ID: 22936564
[TBL] [Abstract][Full Text] [Related]
37. Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States.
Stenmark MH; Shumway D; Guo C; Vainshtein J; Mierzwa M; Jagsi R; Griggs JJ; Banerjee M
Laryngoscope; 2017 Oct; 127(10):2270-2278. PubMed ID: 28304083
[TBL] [Abstract][Full Text] [Related]
38. Oropharyngeal squamous cell carcinoma: radiomic machine-learning classifiers from multiparametric MR images for determination of HPV infection status.
Suh CH; Lee KH; Choi YJ; Chung SR; Baek JH; Lee JH; Yun J; Ham S; Kim N
Sci Rep; 2020 Oct; 10(1):17525. PubMed ID: 33067484
[TBL] [Abstract][Full Text] [Related]
39. Events prediction after treatment in HPV-driven oropharyngeal carcinoma using machine learning.
Dinia A; Ammari S; Filtes J; Classe M; Moya-Plana A; Bidault F; Temam S; Blanchard P; Lassau N; Gorphe P
Eur J Cancer; 2022 Aug; 171():106-113. PubMed ID: 35714450
[TBL] [Abstract][Full Text] [Related]
40. A Prospective Cohort Study of Human Papillomavirus-Driven Oropharyngeal Cancers: Implications for Prognosis and Immunisation.
Wakeham K; Pan J; Pollock KG; Millan D; Bell S; McLellan D; McPhaden A; Conway DI; Graham SV; Kavanagh K; Cuschieri K
Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):e132-e142. PubMed ID: 31248692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
